An bai wa JYMed lambar yabo ta Turai don sabbin hanyoyin kirkirar ta na Liraglutide. Wannan ci gaban yana nuna ci gaba da jagoranci a cikin peptide R&D da IP. Wannan lamban kira yana wakiltar sabon tsari don haɗa liraglutide, wanda ba wai kawai yana tabbatar da yawan amfanin ƙasa ba amma kuma yana rage haɓakar ƙazantaccen jinsin [D-Thr ^ 5] -Liraglutide, wanda yayi kama da samfurin da aka yi niyya. Wannan sabon abu yana haɓaka ingancin samfuran gabaɗaya.

Samun wannan haƙƙin mallaka na Turai yana nuna cikakkiyar damar R&D na kamfanin, yana ƙara ƙarfafa fa'idodin fasaha. Yana ba da gudummawa ga ƙarfafa ainihin gasa ta JYMed da faɗaɗa kasancewarta a kasuwannin duniya. Bugu da ƙari, yana ƙarfafa fa'idodin mallakar fasaha na kamfani, yana taimakawa don kiyayewa da haɓaka gasa ta kasuwannin duniya.

Hubei JXBio Pharmaceutical Co., Ltd, wani reshen Shenzhen JYMed Technology Co., Ltd, ya sami sanarwar Amincewa da Kasuwa kwanan nan don Sinadarin Magungunan Oxytocin Active (API) wanda Hukumar Kula da Kayayyakin Kiwon Lafiya ta kasar (NMPA) ta kasar Sin ta bayar.

Wannan amincewa yana nuna cewa JXBio's oxytocin API ya cika ka'idojin fasaha na tsari wanda tsarin kimanta magunguna na ƙasa ya saita. Yana nuna muhimmin ci gaba ga kamfanin, yana ƙara haɓaka kayan aikin sa da kuma samar da tushe mai ƙarfi don faɗaɗa kasuwa a ɓangaren oxytocin.
GAME DA JYMED
JYMed babban kamfani ne na biopharmaceutical ƙwararre a cikin bincike mai zaman kansa, haɓakawa, samarwa, da tallace-tallace na samfuran tushen peptide, gami da haɓaka kwangila da sabis na ƙungiyar masana'antu (CDMO). Kamfanin ya himmatu wajen samar da peptide APIs masu inganci da mafita na musamman ga abokan cinikin duniya. Fayil ɗin samfurin ta ya haɗa da dozin na peptide APIs, tare da ainihin samfuran kamar Semaglutide da Terlipressin sun riga sun kammala fassarori na FDA DMF na Amurka.

Kamfanin Hubei JXBio Pharmaceutical Co.,Ltd., Yana aiki da layin samar da peptide API na zamani wanda ya dace da ka'idojin cGMP da FDA ta Amurka, EMA na Turai, da NMPA na kasar Sin suka kafa. Wurin ya haɗa da manyan layukan samarwa na 10 da matukin jirgi kuma ya kafa tsarin kula da ingancin magunguna (QMS) da tsarin kula da lafiyar muhalli da aminci (EHS). Waɗannan suna tabbatar da cewa gaba ɗaya tsari, daga R&D zuwa samarwa, ya dace da mafi girman ƙa'idodin ƙasa da ƙasa. Kamfanin ya sami nasarar wuce binciken bin ka'idodin GMP ta hanyar FDA ta Amurka da NMPA ta China kuma manyan kamfanonin harhada magunguna na duniya sun amince da su don ƙwararrun gudanarwar EHS, wanda ke nuna ƙwazon sa na inganci, aminci, da alhakin muhalli.

Manyan Yankunan Kasuwanci:Rijista da yarda da peptide API na cikin gida da na ƙasashen waje,Dabbobin dabbobi da na kwaskwarima peptides,Sabis na peptide na al'ada, gami da CRO, CMO, da mafita na OEM,Peptide-drug conjugates (PDCs), gami da peptide-radionuclide, peptide-kananan kwayoyin halitta, peptide-protein, da peptide-RNA therapeutics..

BABBAN KAYANA

Don ƙarin cikakkun bayanai kan samfuranmu, da fatan za a tuntuɓe mu.

API ɗin Duniya da Ƙwararrun Tambayoyi: Tel No.: +86-15013529272;

API ɗin Rajista & Sabis na CDMO (Kasuwar EU ta Amurka)Saukewa: +86-15818682250

Imel:jymed@jymedtech.com

Adireshin: benaye 8 & 9, Ginin 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen